Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-25 @ 3:47 AM
NCT ID:
NCT01364402
Eligibility Criteria:
Inclusion Criteria:
* Over 18 years of age.
* Diabetic patients.
* eGFR \< 60 ml/min/1.73m2.
* Scheduled for primary or elective PCI.
Exclusion Criteria:
* Non diabetic patients.
* Patients with eGFR ≥ 60 ml/min/1.73m2.
* Chronic renal replacement therapy.
* Subject with active malignancy.
* Subject with any known history of seizure disorders.
* Subject with polycythemia.
* Uncontrolled hypertension.
* Known allergy or hypersensitivity to EPO.
* Use of EPO 1 week prior to randomization.
* Use of long acting EPO (CERA) during 1 month prior to randomization.
* Use of NAC or bicarbonate during 3 days prior to randomization.
* Contrast media exposure during the last 7 days before randomization.
* Pregnant or lactating women.
* Participation in other clinical trial.
* Refusal or inability to give informed consent due to mental or physical state.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01364402
Study Brief:
Protocol Section:
NCT01364402